Skip to main content
Signal8

Baker Daniel G.

SEC insider (Form 3/4/5 filer). CIK 0002046802. Director at Artiva Biotherapeutics, Inc. (ARTV) and 2 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Sep 10, 2026. Located in SAN DIEGO, CA.

Companies Baker Daniel G. has filed insider reports for

  • Artiva Biotherapeutics, Inc. (ARTV): Director
  • Shattuck Labs, Inc. (STTK): Director
  • Cue Biopharma, Inc. (CUE): Officer, CHIEF DEVELOPMENT OFFICER
Baker Daniel G. profile photo

Baker Daniel G.

CIK: 0002046802

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Artiva Biotherapeutics, Inc. logo
ARTV

Artiva Biotherapeutics, Inc.

Director
Shattuck Labs, Inc. logo
STTK

Shattuck Labs, Inc.

Director
Cue Biopharma, Inc. logo
CUE

Cue Biopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 10, 2026
    Award

    Director Stock Option (Right to Buy)

    Direct
    16.3K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 8, 2026
    Award

    Director Stock Option (Right to Buy)

    Direct
    13.8K shares-
  • Shattuck Labs, Inc. logo
    STTK

    Shattuck Labs, Inc.

    May 29, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    81K shares-
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Apr 9, 2026
    Award

    Stock Option (right to buy)

    Direct
    100K shares-
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Sep 29, 2025
    Award

    Stock Option (right to buy)

    Direct
    50K shares-
  • Shattuck Labs, Inc. logo
    STTK

    Shattuck Labs, Inc.

    Aug 28, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    66.3K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Jun 24, 2025
    Award

    Director Stock Option (Right to Buy)

    Direct
    13.8K shares-
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Mar 21, 2025
    Award

    Stock Option (right to buy)

    Direct
    100K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Jan 28, 2025
    Award

    Director Stock Option (Right to Buy)

    Direct
    27.5K shares-
  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Nov 25, 2024
    Award

    Stock Option (right to buy)

    Direct
    200K shares-

1-10 of 10